Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 79899 [2015-32210]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices
‘‘FOA DP16–001, Panel D, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
tkelley on DSK3SPTVN1PROD with NOTICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32210 Filed 12–22–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Board of Scientific Counselors,
National Center for Health Statistics
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee.
Times and Dates: 11:00 a.m.–5:30
p.m., EST, January 21, 2016.
8:30 a.m.–1:00 p.m., EST, January 22,
2016.
Place: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-U.S. citizens, pre-approval is
required (please contact Gwen Mustaf,
301–458–4500, glm4@cdc.gov, or
Virginia Cain, vcain@cdc.gov at least 10
days in advance for requirements). All
visitors are required to present a valid
form of picture identification issued by
a state, federal or international
government. As required by the Federal
Property Management Regulations, Title
41, Code of Federal Regulation, Subpart
101–20.301, all persons entering in or
on Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 100
people.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DP 16–001, Pregnancy Risk
Assessment Monitoring System
(PRAMS).
Time and Date: 12:00 p.m.–6:00 p.m.,
EST, Panel B, February 2, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–001, Panel B, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Jkt 238001
[FR Doc. 2015–32208 Filed 12–22–15; 8:45 am]
Centers for Disease Control and
Prevention
[FR Doc. 2015–32209 Filed 12–22–15; 8:45 am]
18:05 Dec 22, 2015
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
VerDate Sep<11>2014
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
79899
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DP 16–001, Pregnancy Risk
Assessment Monitoring System
(PRAMS).
Times and Dates: 10:00 a.m.–6:00
p.m., EST, Panel A1, January 20–21,
2016 (Closed). 10:00 a.m.–6:00 p.m.,
EST, Panel A2, January 27–28, 2016
(Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–001, Panel A, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Page 79899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32210]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA) DP
16-001, Pregnancy Risk Assessment Monitoring System (PRAMS).
Times and Dates: 10:00 a.m.-6:00 p.m., EST, Panel A1, January 20-
21, 2016 (Closed). 10:00 a.m.-6:00 p.m., EST, Panel A2, January 27-28,
2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``FOA DP16-001, Panel A, Pregnancy Risk Assessment Monitoring System
(PRAMS)''.
Contact Person for More Information: Jayalakshmi Raman, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80,
Atlanta, Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-32210 Filed 12-22-15; 8:45 am]
BILLING CODE 4163-18-P
